Avectas was founded in 2012 by Shirley O’Dea and Michael Maguire. The company is headquartered in Maynooth University, Kildare, Ireland, with an office in Cambridge, Massachusetts.
Avectas is a cell engineering technology business focused on improving the cost, manufacturing, and patient outcomes for the next generation of cellular therapies. We are currently developing the clinical (cGMP) technology embodiment while enhancing its dataset, implementing its commercialization strategy, and building of the team.
